REGN · Regeneron Pharmaceuticals, Inc.

$655.90 +3.99 (+0.61%) At close · Jul 24

Market Cap

$68.78B

104.84M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score

65/100

Short interest 3.3% of shares — P61 Days to cover 4.7 — P65 Price vs VWAP +0.4% — P61 Short-volume trend +2.5% — P52 Short interest change +0.2% — P51 Worst FTD 0.00% of shares — P17 Earnings soon +10

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All

Short Interest History

Settlement Date	Current Position	Previous Position	Change	Avg Daily Volume	Days to Cover
2026-08-14 Scheduled FINRA publishes Aug 25	—	—	—	—	—
2026-07-31 Scheduled FINRA publishes Aug 11	—	—	—	—	—
2026-07-15	3,501,203	3,494,420	+6,783	741,224	4.72
2026-06-30	3,494,420	3,304,329	+190,091	1,199,840	2.91
2026-06-15	3,304,329	3,001,968	+302,361	968,690	3.41
2026-05-29	3,001,968	2,780,809	+221,159	1,532,432	1.96
2026-05-15	2,780,809	3,270,341	-489,532	764,041	3.64
2026-04-30	3,270,341	2,841,780	+428,561	805,112	4.06
2026-04-15	2,841,780	2,548,311	+293,469	651,908	4.36
2026-03-31	2,548,311	2,451,498	+96,813	604,079	4.22
2026-03-13	2,451,498	2,286,750	+164,748	586,546	4.18
2026-02-27	2,286,750	2,051,997	+234,753	606,073	3.77
2026-02-13	2,051,997	2,176,530	-124,533	823,603	2.49
2026-01-30	2,176,530	2,289,214	-112,684	929,677	2.34
2026-01-15	2,289,214	2,484,091	-194,877	894,421	2.56
2025-12-31	2,484,091	2,738,113	-254,022	753,196	3.30
2025-12-15	2,738,113	3,148,430	-410,317	974,712	2.81
2025-11-28	3,148,430	2,844,265	+304,165	1,292,803	2.44
2025-11-14	2,844,265	2,793,459	+50,806	960,953	2.96
2025-10-31	2,793,459	2,927,169	-133,710	1,014,914	2.75
2025-10-15	2,927,169	2,760,203	+166,966	1,188,676	2.46
2025-09-30	2,760,203	2,985,318	-225,115	1,168,677	2.36
2025-09-15	2,985,318	2,827,689	+157,629	960,752	3.11
2025-08-29	2,827,689	2,349,138	+478,551	959,124	2.95
2025-08-15	2,349,138	2,291,886	+57,252	1,061,943	2.21
2025-07-31	2,291,886	2,074,491	+217,395	920,278	2.49

Showing 1–24 of 24 settlements

Key facts CIK 872589 CUSIP 75886F107 13F (30d) 345 filings 341 filers Visit website Investor relations